Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS 2004 - EWS CARDS 2004, Component 4 Early Warning System Tim Pfeiffer-Gerschel National Focal Point.

Slides:



Advertisements
Similar presentations
Role of WMO in Natural Disaster Risk Reduction Ivan Obrusník, Czech Hydrometeorological Institute Role of WMO in Natural Disaster Risk Reduction Ivan Obrusník,
Advertisements

Ministry of Labor and Social Policy SOCIAL POLICY COUNCILS Dragica Vlaović-VasiljevićSophia, 2-6th July 2007 Dragica Vlaović-VasiljevićSophia, 2-6th July.
Child Protection Units
Government of the Republic of Serbia Ministry of Labor and Social Policy GENERAL AND SPECIAL PROTOCOL ON CHILD PROTECTION FROM ABUSE AND NEGLECT.
Claudia de Windt Senior Legal Specialist Department of Sustainable Development Strengthening Humanitarian Assistance and Prevention and Response Coordination.
TREATMENT DATA INDICATORS IN THE UNODC DATA COLLECTION SYSTEM.
The EMCDDA and the Reitox network: towards quality achievement Sandrine Sleiman, Scientific Committee, Palmela, February 2008.
Overview of the 2011 Work Programme Paul Griffiths Scientific committee meeting, Lisbon, November 2010.
Panel themes of the International Conference “Europe against Counterfeit Medicines” G.N. Gildeeva, Deputy head of the Department of Registration of Medicines.
EU Cross-Border Care Directive from the Primary Care perspective Results of a simulation Rita Baeten Gothenburg, 3 September 2012.
Law approximation and implementation in Hungary Ministry for Environment Department of Integrated Pollution Control Nicosia, May 2001 Andrea Nám, desk.
Bylaw on drug demand reduction in Serbia. Bylaw(s) - principles  should be based on existing law(s)  should complement existing laws  should not be.
European Early Warning System Charlotte Davies. European Early Warning System Adopted in May 2005, the Council Decision 2005/387/JHA on the information.
Strenghtening collaboration with Serbia - IPA4 Project expected outcomes Frédéric Denecker, Programme Management Officer Reitox and International Cooperation.
2011 Overall Objectives Contributing toward limiting Violence against Women, and fostering the role of the NCHR in combating VAW focusing on domestic.
Regulatory Body MODIFIED Day 8 – Lecture 3.
Information needs for effective drug policy in the programme of the CZ PRES Identifying Europe’s information needs for effective drug policy Lisbon /
The REITOX Experience Lessons learned in developing a network of National Drugs Focal Points and challenges for the future Alan Lodwick, Head of UK National.
European Monitoring Centre for Drugs and Drug Addiction Margareta Nilson ISAJE, Helsinki, 1 September 2006.
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
Central Asia Regional Health Security Workshop Co-organized with the Command Surgeon, US Central Command and the George C. Marshall European Center for.
STRENGTHENING the AFRICA ENVIRONMENT INFORMATION NETWORK An AMCEN initiative A framework to support development planning processes and increase access.
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
Municipal Drug Policy Legislation, institutions and programs Assoc. Prof. Hristo Bozov, MD, PhD Deputy-Mayor of Municipality of Varna Chairman of Municipal.
Quality Assurance at the European Monitoring Centre for Drugs and Drug Addiction Sandrine Sleiman European Conference on Quality in Official Statistics,
Programming of International Development Assistance Donor Meeting Agency for Human and Minority Rights September 27, 2007.
REGIONAL HEALTHCARE CENTER ASSOC. PROF. D-R PETKO SALCHEV PhD.
Course: European Criminal Law SS 2009 Hubert Hinterhofer.
Community agencies: partners in accession Cooperation with EMCDDA - Polish experience Boguslawa Bukowska, National Bureau for Drug Prevention ,
Croatian Report on new Environmental Protection Law Josipa Blažević-Perušić, B.Sc. Arch. State Secretary Anita Pokrovac-Patekar, B.Sc. Pharm. Senior Environmental.
Washington D.C., USA, July 2012www.aids2012.org The HIV/AIDS Civil Society Forum and Think Tank: from policy to action Anna Zakowicz HIV/AIDS Civil.
Local Public Health System Assessment using the NPHPSP Local Instrument Essential Service 6 Enforce Laws and Regulations that Protect Health and Ensure.
Marina Kuzman, MD, PhD Croatian National Institute of Public Health National Drug Prevention and Information System in the Republic of Croatia - impact.
International Atomic Energy Agency THE “EMERGENCY CONVENTIONS” Interregional Training Course on Technical Requirements to Fulfil National Obligations in.
Understanding TASC Marc Harrington, LPC, LCASI Case Developer Region 4 TASC Robin Cuellar, CCJP, CSAC Buncombe County.
Information Sharing Challenges, Trends and Opportunities
Telematikplattform für Medizinische Forschungsnetze (TMF) e.V. TMF – A Common Platform for Medical Research Networks in Germany Improving the Organisation.
Project “Identifying Common Interests for Social Dialogue in the Waste Industry” Mathias Maucher Policy Officer “Health and Social Services” European Federation.
Twinning Project Implementation of Strategy for Fight Against Drugs in Serbia Kick off and Assessment November 2012 Belgrade.
Components of a national drug prevention system Ms. UNODC.
European Commission 1 By Sue BIRD European Commission, DG Employment, Social Affairs and Equal Opportunities Brussels, 17 December 2008 CECOP – CICOPA.
Twinning Project SR 10 IB JH 02 Twinning Project SR 10 IB JH 02 Implementation of Strategy for Fight Against Drugs (Supply and Demand Reduction Component)
Implementation of the Substitution Maintenance Therapy in the framework of the Programme “Overcoming HIV/AIDS Epidemics in Ukraine” Stakeholders meeting.
Greek experience on the enforcement of Product Safety legislation Community safety legislation and current situation in Greece.
OVERVIEW OF THE ROLES OF VARIOUS INSTITUTIONS AND REGULATORY FRAMEWORK FOR AFLATOXIN CONTROL IN TANZANIA RAYMOND N. WIGENGE DIRECTOR OF FOOD SAFETY TFDA.
Lisbo n, Novem b er Bosnia and Herzegovina Ministry of Civil Affairs Sector for Health COMMUNITY AGENCIES: PARTNERS IN ACCESSION The point.
Donor Coordination Forum 16 October, key challenges Poverty Social exclusion Functional gaps and system weaknesses in social services.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
EUnetHTA Joint Action 2010–2012 | EUnetHTA Joint action Sharing expertise and efforts Iris Pasternack, research officer, FINOHTA.
Guidance in LLL concept – from strategies to practice Tereza Listová, MoEYS, NGF Silvie Pýchová, EG, ELGPN.
BMH CLINICAL GUIDELINES IN EUROPE. OUTLINE Background to the project Objectives The AGREE Instrument: validation process and results Outcomes.
Parallel Session B - Implementation issues Policy perspectives.
HTA Benefits and Risks Dr Bernard Merkel European Commission.
Strengthening of continues medical education system in SRH&R Aigul Azimova Kyrgyz State Medical Institute for Retraining and Continuous Education Bishkek.
Participants Q.1: Which of these categories describes your work best? 1.Work on sustainable development regarding pharmaceuticals mainly at national level.
Overview of EMCDDA’s 2009 Scientific Work Programme Paul Griffiths, Roland Simon - REITOX Meeting, Lisbon, November 2007.
EUNetPaS is a project supported by a grant from the EAHC. The sole responsibility for the content of this presentation lies with the author(s). The EAHC.
Monitoring and reporting on the drug phenomenon in Europe EMCDDA mandate and activities Wolfgang Götz, Scientific Committee, Palmela, 14 February 2008.
DEMOCRACY, CITIES AND DRUGS II Project French National Platform.
First European conference on drug supply indicators, , Brussels – Feed-back Chloé Carpentier, Laurent Laniel, EMCDDA 33 rd meeting of the.
Human Trafficking in Bosnia and Herzegovina SAMIR RIZVO State Coordinator for Combating Trafficking in Human Beings and Illegal Migration.
A network of European National Platforms and Focal Points for Natural Disaster Reduction Common Goals To facilitate and improve the exchange of information.
Evaluation of Action Plan Turkish Monitoring Center for Drugs and Drug Addiction TUBIM.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
SOCIAL INCLUSION IN EASTERN EUROPE AND CENTRAL ASIA TOWARDS MAINSTREAMING AND RESULTS SOCIAL INCLUSION IN EASTERN EUROPE AND CENTRAL ASIA TOWARDS MAINSTREAMING.
Establishment of NGO info points for NPS sample collection within regional EWS in the framework of I-SEE project Ada Hočevar Grom,
European Social Fund and Social Partners Partnership Joint actions in all Members States Capacity building in Convergence Regions DG Employment,
Role of the Council of Europe - International Partner Organisation Justice Programme Prague, 20 March 2019 Criminal Law Cooperation Unit Action against.
Role of the Council of Europe - International Partner Organisation Justice Programme Prague, 20 March 2019 Criminal Law Cooperation Unit Action against.
THE LABOUR ADMINISTRATION AND INSPECTION PROGRAMME LAB/ADMIN
Presentation transcript:

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS CARDS 2004, Component 4 Early Warning System Tim Pfeiffer-Gerschel National Focal Point for the EMCDDA, Germany Tim Pfeiffer-Gerschel National Focal Point for the EMCDDA, Germany

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS Different perspectives  National needs and interests  European requirements

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS Different perspectives  National needs and interests  European requirements

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS Again: Background… 1995: Joint Action on the information exchange, risk assessment and the control of new synthetic drugs 2005: Council decision on the information exchange, risk assessment and the control of new psychoactive substances

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS Council decision – extended scope Extension Inclusion of biogenic drugs Inclusion of misuse of pharmaceutic drugs Cooperation EMCDDA - EMEA Limited reactions Risk assessment no longer mandatory

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS Consequences on national level Increasing role of information from the toxicological centres Inclusion of the national system on misuse of pharmaceutics Increasing cooperation with regional networks Define the limitations together with the national policy and EMCDDA

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS Different perspectives  National needs and interests  European requirements

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS General approach Local Panel Comparision with existing information Risk: Overinterpretation Chance: Sensitivity Information Validation Coordination: NFP

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS Key elements – national level Health and Epidemiology Others Treatment sources Law enforcement sources Outreach sources National Focal Point (validation, notification) Laboratories

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS Routes of reporting European Police Office (Hague) Information on the manufacture, traffic and use, possible medical use EMCDDA (Lisbon) Federal Criminal Police, BKA REITOX Focal Point European Commission (EC) European Medicines Agency (EMEA) Report New psychoactive substance from police sources New psychoactive substance from health/care system

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS Problems…  Delays in toxicological analyses  Difficulties in providing a fast response  High costs and efforts for chemical analyses  Restricted application  Exchange of information between police, treatment system and NFP  Problems with operational data  Problems to link effects and (new) substance

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS  No Pill-testing: political, legal and technical aspects  Systematic data collection nearly exclusively by police  Limited feed-back to treatment system  Additional input:  Toxicology information centres  Regional EWSs in Hamburg and Frankfurt Framework

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS But… Active network, experts from…  Treatment centres (Frankfurt)  Regional monitoring systems (Frankfurt, Hamburg)  Police (Federal Criminal Police)  Emergency hotlines  Federal Institute of Pharmaceutical Devices  Representative of Länder-level

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS Complementary elements „Minimal solution“ Re-analyses of existing data Optimisation of analyses and information workflow Establishment of an additional network Link to existing data sources Broad Concept (2)(1)

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS What has happened during CARDS 2004?

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS Aim… (Intervention logic)  Assessment regarding needs and requirements for an early warning system  Development of an Early Warning System (EWS) on new psychoactive substances  Adoption by relevant ministerial and governmental commissions  Preparation of implementation through training of key staff  Practice oriented assistance in the implementation

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS Steps taken  Assessment regarding existing structures and future requirements for EWS Management System  Multidisciplinary working group formed (Ministry of Interior: Police Directorate and Forensic Laboratory, Ministry of Health and Social Welfare, Institute of Public Health, Medical University, State Attorney Office, Treatment Centres)  Draft of new EWS developed based on own experiences, EMCDDA requirements and experiences from MS: Protocol and interministerial agreement  Study visit to Austria and Germany  Adoption of EWS model by governmental institutions  Assistance in the implementation, training of key persons

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS Sources of information  Experiences from different Croatian partners:  Forensic lab of Ministry of Interior and other forensic medicine labs (clinical hospitals) – toxicological information  Ministry of Health and Social Welfare – additional information e.g. on medical products  Police – more qualitative information from street level  Harm reduction projects – more qualitative informa- tion from street level  Centres for Prevention and Treatment  Institute of Public Health  Experiences in MS

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS Experiences  Good cooperation between care and criminal justice system, willingness to share information  Participants adequate in number and qualification  Professional work  Utilisation of existing networks  Very good starting point, clear structure and well elabo- rated concept

Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS Perspective  A network depends on its partners  Active participation is a key for further de- velopment and access to new information  The ground has been prepared…